SCHEMBL9239243

SCHEMBL9239243

CCCCCC1=CC2(C=C1CCCCC)CCC2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.36
BACE1 P56817 1/20 0.36
CYP19A1 P11511 4/20 0.34
PTGS2 P35354 8/20 0.33
ALOX5 P09917 4/20 0.33
CYP3A4 P08684 2/20 0.32
PTPN1 P18031 1/20 0.32
GLS2 Q9UI32 1/20 0.32
ESR1 P03372 2/20 0.31
ADRA2A P08913 2/20 0.31
ADORA3 P0DMS8 2/20 0.31
TACR2 P21452 2/20 0.31
SLC6A2 P23975 2/20 0.31
SLC6A4 P31645 2/20 0.31
SLC6A3 Q01959 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
SHBG P04278 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9235961 0.91 ACHE (0.38) ACHEBACE1CYP19A1PTGS2ALOX5
SCHEMBL9236406 0.74 TDP1 (0.44) CYP19A1CYP3A4ALDH1A1
SCHEMBL8518767 0.64 SCD (0.37)
SCHEMBL7639225 0.62 PTGS2 (0.39) ACHEPTGS2CYP3A4ESR1ADRA2A
Hexane SCHEMBL18764545 0.58 TSHR (0.64) ALDH1A1LMNAHSD17B10
Cyclohexane SCHEMBL10572382 0.58 TSHR (0.64) ALDH1A1LMNAHSD17B10
Cyclohexane SCHEMBL12475770 0.58 TSHR (0.64) ALDH1A1LMNAHSD17B10
Cyclohexane SCHEMBL5787824 0.58 TSHR (0.64) ALDH1A1LMNAHSD17B10
Cyclohexane SCHEMBL11423653 0.58 TSHR (0.64) ALDH1A1LMNAHSD17B10
Cyclohexane SCHEMBL10453382 0.58 TSHR (0.64) ALDH1A1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995030652-A1 SUBSTITUTED SPIRODIENES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed